We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
(+11%)
Cap. Flow
+$263M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$35.7M |
| 2 |
Merck
MRK
|
+$30.3M |
| 3 |
Microsoft
MSFT
|
+$22.4M |
| 4 |
Yum China
YUMC
|
+$17.6M |
| 5 |
Occidental Petroleum
OXY
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$36.5M |
| 2 |
Intel
INTC
|
+$32.4M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$17.1M |
| 4 |
NVR
NVR
|
+$16.3M |
| 5 |
Deere & Co
DE
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Financials | 17.92% |
| 3 | Industrials | 13.48% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Healthcare | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Nu Skin
NUS
$247M
| $6.8M | 0.12% |
+99,713
| New | +$6.45M |
|
227
Benchmark Electronics
BHE
$2.91B
| $6.77M | 0.12% |
232,681
+9,178
| +4% | +$286K |
|
228
Boise Cascade
BCC
$2.74B
| $6.76M | 0.12% |
169,380
+22,720
| +15% | +$842K |
|
|
LNW
229
DELISTED
Light & Wonder
LNW
| $6.72M | 0.12% |
130,920
-81,490
| -38% | -$3.97M |
|
230
Cognizant
CTSH
$21.5B
| $6.67M | 0.12% |
+93,910
| New | +$6.86M |
|
231
JB Hunt Transport Services
JBHT
$27.1B
| $6.66M | 0.12% |
57,924
+32,390
| +127% | +$3.49M |
|
|
ALOG
232
DELISTED
Analogic Corp
ALOG
| $6.52M | 0.11% |
77,870
+46,315
| +147% | +$3.83M |
|
|
ARGO
233
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $6.46M | 0.11% |
120,511
+21,671
| +22% | +$1.16M |
|
234
Manitowoc
MTW
$516M
| $6.44M | 0.11% |
163,777
+44,129
| +37% | +$1.71M |
|
|
TGI
235
DELISTED
Triumph Group
TGI
| $6.42M | 0.11% |
236,009
-43,350
| -16% | -$1.3M |
|
236
Itron
ITRI
$3.73B
| $6.37M | 0.11% |
93,350
+70,510
| +309% | +$5.04M |
|
237
Adtran
ADTN
$798M
| $6.35M | 0.11% |
328,159
+65,081
| +25% | +$1.44M |
|
238
MasTec
MTZ
$26.7B
| $6.34M | 0.11% |
129,600
-5,570
| -4% | -$248K |
|
239
Conduent
CNDT
$230M
| $6.18M | 0.11% |
382,605
+218,005
| +132% | +$3.41M |
|
|
EGN
240
DELISTED
Energen
EGN
| $6.17M | 0.11% |
107,223
-600
| -0.6% | -$32.6K |
|
241
Telephone and Data Systems
TDS
$3.91B
| $6.15M | 0.11% |
221,218
+141,766
| +178% | +$3.89M |
|
|
ABMD
242
DELISTED
Abiomed Inc
ABMD
| $6.11M | 0.11% |
32,591
+11,893
| +57% | +$2.22M |
|
243
Teradyne
TER
$54.8B
| $6.09M | 0.11% |
145,460
-400
| -0.3% | -$16.5K |
|
244
Avient
AVNT
$3.45B
| $6.05M | 0.11% |
139,065
+28,310
| +26% | +$1.24M |
|
245
Southwest Gas
SWX
$6.74B
| $6.04M | 0.11% |
75,084
+13,784
| +22% | +$1.12M |
|
246
Primoris Services
PRIM
$4.69B
| $6M | 0.11% |
220,503
+102,401
| +87% | +$2.85M |
|
247
TriNet
TNET
$2.84B
| $5.97M | 0.1% |
134,553
-65,465
| -33% | -$2.62M |
|
248
ONE Gas
OGS
$5.05B
| $5.9M | 0.1% |
80,534
-22,325
| -22% | -$1.69M |
|
249
Lattice Semiconductor
LSCC
$17.6B
| $5.88M | 0.1% |
+1,018,209
| New | +$5.97M |
|
250
Medifast
MED
$108M
| $5.88M | 0.1% |
84,253
+78,123
| +1,274% | +$5.18M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2017 Portfolio in Review
As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.
- Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
- Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
- Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
- Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.